3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Laryngeal Neoplasms
3
Head and Neck Neoplasms
3
Uterine Cervical Neoplasms
2
Stomatitis
2
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Hematologic Neoplasms
2
Dyspareunia
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vomiting
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Squamous Intraepithelial Lesions
1
Soft Tissue Neoplasms
1
Radiodermatitis
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Pain
1
Ovarian Neoplasms
1
Neoplasms
1
Mucositis
1
HIV Infections
1
Endometrial Neoplasms
1
Eczema
1
Dermatitis
1
Cicatrix
1
Cancer Pain
1
Interventions
VGX-3100
4
Light Coagulation
3
Watchful Waiting
2
Polymerase Chain Reaction
2
Imiquimod
2
Fluorouracil
2
Electroporation
2
Cidofovir
2
4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone
2
Solutions
1
Radiofrequency Ablation
1
Observation
1
Mindfulness-Based Stress Reduction
1
Laser Therapy
1
Immunohistochemistry
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Histological Techniques
1
Gene Expression Profiling
1
Folic Acid
1
Electroporation Therapies
1
Data Collection
1
DNA Methylation
1
Blue Light
1
Biopsy
1
Aminolevulinic Acid
1
5-aminolaevulinic acid-n-pentylester
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Squamous Intraepithelial Lesions
×
Laser Therapy
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts